{"id":247,"date":"2015-02-05T16:59:14","date_gmt":"2015-02-05T21:59:14","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=247"},"modified":"2015-02-05T16:59:14","modified_gmt":"2015-02-05T21:59:14","slug":"secondarys-announced-2-5-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondarys-announced-2-5-2015\/","title":{"rendered":"Secondary&#8217;s Announced 2.5.2015"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet <a href=\"https:\/\/www.ipoboutique.com\/cgi\/secondaries-stock-track-record-summary.php\" target=\"_blank\">maintains a track record<\/a> for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, <a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">click here. <\/a><\/p>\n<p>Company: <strong>Ohr Pharmaceutical, Inc.<\/strong><!--more--><br \/>\nSymbol: OHRP<br \/>\nPrice: Last trade $7.64<br \/>\nTrade Date: 2\/6<br \/>\nShares: TBD<br \/>\nUnderwriter(s) Cowen &amp; Co.<br \/>\nCo Manager(s) LifeSci Capital<br \/>\nRating=<a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/p>\n<p>Company: <strong>Navios Maritime<\/strong><br \/>\nSymbol: NMM<br \/>\nPrice: Last trade $13.71<br \/>\nTrade Date: 2\/6<br \/>\nShares: 4 million<br \/>\nUnderwriter(s) BofA Merrill Lynch, Citigroup, J.P. Morgan, Deutsche Bank, Credit Suisse<br \/>\nCo Manager(s) S. Goldman Capital<br \/>\nRating=<a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/p>\n<p>Company: <strong>TrovaGene, Inc.<\/strong><br \/>\nSymbol: TROV<br \/>\nPrice: Last trade $5.85<br \/>\nTrade Date: 2\/6<br \/>\nShares: 3.4 million<br \/>\nUnderwriter(s) Piper Jaffray<br \/>\nRating=<a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, click here. Company: Ohr Pharmaceutical, Inc.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[102,101,103],"class_list":["post-247","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-nmm","tag-ohrp","tag-trov"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=247"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/247\/revisions"}],"predecessor-version":[{"id":248,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/247\/revisions\/248"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}